Brief: Amicus Therapeutics Announces Q3 2024 Financial Results And Corporate Updates
06/11/2024 12:13
Nov 6 (Reuters) - Amicus Therapeutics Inc FOLD.O :
* AMICUS THERAPEUTICS ANNOUNCES THIRD QUARTER 2024 FINANCIAL
RESULTS AND CORPORATE UPDATES
* AMICUS THERAPEUTICS INC: RAISING 2024 TOTAL REVENUE
GROWTH
GUIDANCE TO 30%-32% AT CER
* AMICUS THERAPEUTICS INC OUTLOOK FY REDUCING NON-GAAP
OPERATING
EXPENSE GUIDANCE TO $340 MILLION TO $350 MILLION
Source text: ID:nGNX9GZJF9
Further company coverage: FOLD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Amicus Therapeutics
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Amicus Q4 revenue beats estimates